Case Report
BibTex RIS Cite

Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma

Year 2022, Volume: 2 Issue: 2, 25 - 26, 01.08.2022

Gökçe Yavan Zehra Pınar Koç Pınar Pelin Özcan

Abstract

Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (18F-FDG) is currently a standard imaging examination used in clinical practice, and plays an essential role in preoperative systemic evaluation and tumor staging in various cancer patients. With this method, it is possible to measure or compare metabolic changes in cancer cells. With combined PET/CT, it is possible to determine the correct anatomical location in hypermetabolic tumors with uptake of FDG. In this review, we presented the a case with disseminated abdominal mass diagnosed as Burkitt Lymphoma diagnosed by FDG-PET-CT

Keywords

F18- FDG PET-CT Abdomen

References

  • 1. Sachpekidis, C., Exadaktylou, P., Katsampoukas, D., Moralidis, E., & Arsos, G. (2020). 18F-FDG PET/CT in treatment response evaluation of Burkitt lymphoma: complete remission of a peritoneal super scan. Hellenic journal of nuclear medicine, 23(1), 76–78. https://doi.org/10.1967/s002449912006
  • 2. Zeng, W., Lechowicz, M. J., Winton, E., Cho, S. M., Galt, J. R., & Halkar, R. (2009). Spectrum of FDG PET/CT findings in Burkitt lymphoma. Clinical nuclear medicine, 34(6), 355–358. https://doi.org/10.1097/RLU.0b013e3181a34552
  • 3. Wang, X., Chen, Z., Tang, G., & Zhang, X. (2011). A child with Burkitt lymphoma with pleural, peritoneal, mesenteric, omental, and renal involvement: diagnostics by FDG PET/CT. Clinical nuclear medicine, 36(7), 612–615. https://doi.org/10.1097/RLU.0b013e318217af84
There are 3 citations in total.

Details

Primary Language English
Subjects Oncology and Carcinogenesis
Journal Section Case Reports
Authors

Gökçe Yavan This is me 0000-0002-7332-6293

Zehra Pınar Koç This is me 0000-0002-3274-5790

Pınar Pelin Özcan This is me 0000-0003-0147-2678

Publication Date August 1, 2022
Published in Issue Year 2022 Volume: 2 Issue: 2

Cite

APA Yavan, G., Koç, Z. P., & Özcan, P. P. (2022). Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging, 2(2), 25-26.
AMA Yavan G, Koç ZP, Özcan PP. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. August 2022;2(2):25-26.
Chicago Yavan, Gökçe, Zehra Pınar Koç, and Pınar Pelin Özcan. “Abdominal Mass Shown by the FDG PET/CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging 2, no. 2 (August 2022): 25-26.
EndNote Yavan G, Koç ZP, Özcan PP (August 1, 2022) Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging 2 2 25–26.
IEEE G. Yavan, Z. P. Koç, and P. P. Özcan, “Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma”, Molecular Oncologic Imaging, vol. 2, no. 2, pp. 25–26, 2022.
ISNAD Yavan, Gökçe et al. “Abdominal Mass Shown by the FDG PET/CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging 2/2 (August 2022), 25-26.
JAMA Yavan G, Koç ZP, Özcan PP. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022;2:25–26.
MLA Yavan, Gökçe et al. “Abdominal Mass Shown by the FDG PET/CT With Diagnosis of Burkitt Lymphoma”. Molecular Oncologic Imaging, vol. 2, no. 2, 2022, pp. 25-26.
Vancouver Yavan G, Koç ZP, Özcan PP. Abdominal Mass shown by the FDG PET/CT with diagnosis of Burkitt Lymphoma. Molecular Oncologic Imaging. 2022;2(2):25-6.